India has developed a novel antibiotic to fight antimicrobial resistance (AMR), as well as a new drug to tackle burden of ...

The FDA has given the green light to Exblifep, based on long-established beta-lactam antibiotic cefepime and a new extended-spectrum beta-lactamase inhibitor (BLI) called enmetazobactam ...

Orchid Pharma Ltd., a vertically integrated pharmaceutical company, has received seven minor observations from the U.S. Food ...

The second day of the 9th "International Symposium on Current Trends in Drug Discovery Research” at CSIR-Central Drug Research Institute, Lucknow, observed important scientific deliberations by ...

Its lead combination - cefepime-taniborbactam – is being developed in phase 3 trials for complicated urinary tract infections (cUTI), hospital-acquired bacterial pneumonia, and ventilator ...

Clinical trials conducted in patients with CAP treated on an outpatient basis provide relevant data for clinicians dealing with management of this common serious infection. A number of trials have ...